2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Andre H. Goy, MD, discusses the importance of refined decision making with precision medicine.
Andre H. Goy, MD, Physician in Chief Hackensack Meridian Health Oncology Care Transformation Service, Chairman & Chief Physician Officer - John Theurer Cancer Center, Lydia Pfund Chair for Lymphoma, Academic Chairman Oncology - Hackensack Meridian School of Medicine, Professor of Medicine – Georgetown University, Hackensack, NJ, discusses the importance of refined decision making with precision medicine.
When looking at precision medicine, it is important to have one consistent definition, Goy says. Precision medicine is not a new concept, as it was first utilized in the 19th century, and has been expanding rapidly in recent years, Goy explains. The misconception of precision medicine is that treatment can be personalized to each individual patient; however, treatment decisions are informed by available clinical and molecular data that allow for the refinement and optimization of treatment options, Goy notes.
To implement precision medicine strategies, it is important to organize all available knowledge and data to then apply it to clinical practice, optimize treatment, and provide patients with the best possible outcome, Goy concludes.